SK17682002A3 - Liečivá na prevenciu a liečbu neurodegeneratívnych ochorení - Google Patents
Liečivá na prevenciu a liečbu neurodegeneratívnych ochorení Download PDFInfo
- Publication number
- SK17682002A3 SK17682002A3 SK1768-2002A SK17682002A SK17682002A3 SK 17682002 A3 SK17682002 A3 SK 17682002A3 SK 17682002 A SK17682002 A SK 17682002A SK 17682002 A3 SK17682002 A3 SK 17682002A3
- Authority
- SK
- Slovakia
- Prior art keywords
- naphthyridin
- oxadiazol
- treatment
- substituted
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000185814 | 2000-06-21 | ||
| PCT/JP2001/004934 WO2001098300A1 (fr) | 2000-06-21 | 2001-06-12 | Medicaments utilises dans la prevention et le traitement de maladies neurodegeneratives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK17682002A3 true SK17682002A3 (sk) | 2003-08-05 |
Family
ID=18686074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1768-2002A SK17682002A3 (sk) | 2000-06-21 | 2001-06-12 | Liečivá na prevenciu a liečbu neurodegeneratívnych ochorení |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6743803B2 (hu) |
| EP (1) | EP1295883A4 (hu) |
| KR (1) | KR20030010740A (hu) |
| CN (1) | CN100354274C (hu) |
| AU (2) | AU6274101A (hu) |
| BR (1) | BR0111799A (hu) |
| CA (1) | CA2412199A1 (hu) |
| CZ (1) | CZ20024153A3 (hu) |
| EE (1) | EE04941B1 (hu) |
| HU (1) | HUP0301319A3 (hu) |
| IL (2) | IL153439A0 (hu) |
| MX (1) | MXPA02012599A (hu) |
| NO (1) | NO20026148L (hu) |
| NZ (1) | NZ523189A (hu) |
| PL (1) | PL200537B1 (hu) |
| RU (1) | RU2258506C2 (hu) |
| SK (1) | SK17682002A3 (hu) |
| TW (1) | TWI298068B (hu) |
| WO (1) | WO2001098300A1 (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6822097B1 (en) * | 2002-02-07 | 2004-11-23 | Amgen, Inc. | Compounds and methods of uses |
| TW200533371A (en) * | 2004-04-15 | 2005-10-16 | Dainippon Pharmaceutical Co | Medicament comprising a combination of an acetylcholinesterase inhibitor and a 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivative |
| EP1595881A1 (en) * | 2004-05-12 | 2005-11-16 | Pfizer Limited | Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands |
| WO2010002451A1 (en) * | 2008-07-01 | 2010-01-07 | Concert Pharmaceuticals, Inc. | Naphthyridin derivatives |
| JP6551671B2 (ja) * | 2015-08-11 | 2019-07-31 | 国立大学法人 熊本大学 | アルツハイマー治療薬 |
| BR112022000811A2 (pt) * | 2019-07-18 | 2022-03-29 | Abaxys Therapeutics | Formulação sólida de um derivado de 1,2,4-oxadiazol |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2683818B1 (fr) | 1991-11-14 | 1993-12-31 | Adir Cie | Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| JPH09291034A (ja) * | 1996-02-27 | 1997-11-11 | Yoshitomi Pharmaceut Ind Ltd | 縮合ピリジン化合物およびその医薬としての用途 |
| ZA985870B (en) * | 1997-07-15 | 1999-01-27 | Dainippon Pharmaceutical Co | 5-substituted-3-oxadiazolyl-1, 6-naphthyridin-2(1H)-one derivatives |
| AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
| WO2000073283A1 (en) | 1999-06-02 | 2000-12-07 | Nps Pharmaceuticals, Inc. | Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
-
2001
- 2001-06-06 TW TW090113656A patent/TWI298068B/zh not_active IP Right Cessation
- 2001-06-12 EP EP01936958A patent/EP1295883A4/en not_active Withdrawn
- 2001-06-12 BR BR0111799-8A patent/BR0111799A/pt not_active Application Discontinuation
- 2001-06-12 AU AU6274101A patent/AU6274101A/xx active Pending
- 2001-06-12 CA CA002412199A patent/CA2412199A1/en not_active Abandoned
- 2001-06-12 IL IL15343901A patent/IL153439A0/xx active IP Right Grant
- 2001-06-12 RU RU2003101405/04A patent/RU2258506C2/ru not_active IP Right Cessation
- 2001-06-12 EE EEP200200698A patent/EE04941B1/xx not_active IP Right Cessation
- 2001-06-12 WO PCT/JP2001/004934 patent/WO2001098300A1/ja active IP Right Grant
- 2001-06-12 CN CNB018142834A patent/CN100354274C/zh not_active Expired - Fee Related
- 2001-06-12 KR KR1020027017221A patent/KR20030010740A/ko not_active Application Discontinuation
- 2001-06-12 CZ CZ20024153A patent/CZ20024153A3/cs unknown
- 2001-06-12 SK SK1768-2002A patent/SK17682002A3/sk unknown
- 2001-06-12 PL PL363869A patent/PL200537B1/pl not_active IP Right Cessation
- 2001-06-12 US US10/311,932 patent/US6743803B2/en not_active Expired - Fee Related
- 2001-06-12 AU AU2001262741A patent/AU2001262741B2/en not_active Ceased
- 2001-06-12 NZ NZ523189A patent/NZ523189A/en unknown
- 2001-06-12 HU HU0301319A patent/HUP0301319A3/hu unknown
- 2001-06-12 MX MXPA02012599A patent/MXPA02012599A/es active IP Right Grant
-
2002
- 2002-12-15 IL IL153439A patent/IL153439A/en not_active IP Right Cessation
- 2002-12-20 NO NO20026148A patent/NO20026148L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL153439A (en) | 2007-07-24 |
| EP1295883A1 (en) | 2003-03-26 |
| EE200200698A (et) | 2004-08-16 |
| PL200537B1 (pl) | 2009-01-30 |
| NZ523189A (en) | 2004-08-27 |
| TWI298068B (en) | 2008-06-21 |
| US20030166673A1 (en) | 2003-09-04 |
| AU2001262741B2 (en) | 2005-07-07 |
| PL363869A1 (en) | 2004-11-29 |
| WO2001098300A1 (fr) | 2001-12-27 |
| IL153439A0 (en) | 2003-07-06 |
| CN1447809A (zh) | 2003-10-08 |
| NO20026148D0 (no) | 2002-12-20 |
| KR20030010740A (ko) | 2003-02-05 |
| CN100354274C (zh) | 2007-12-12 |
| BR0111799A (pt) | 2003-05-27 |
| EP1295883A4 (en) | 2003-06-11 |
| MXPA02012599A (es) | 2003-05-14 |
| EE04941B1 (et) | 2007-12-17 |
| AU6274101A (en) | 2002-01-02 |
| CA2412199A1 (en) | 2001-12-27 |
| HUP0301319A3 (en) | 2008-06-30 |
| US6743803B2 (en) | 2004-06-01 |
| HUP0301319A2 (hu) | 2003-09-29 |
| RU2258506C2 (ru) | 2005-08-20 |
| NO20026148L (no) | 2003-02-20 |
| CZ20024153A3 (cs) | 2003-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5945416A (en) | Method for treating pain | |
| KR20170003527A (ko) | 경구 투여용 펜토산 폴리설페이트 염의 조성물 | |
| US6262081B1 (en) | Composition for and method of treating neurological disorders | |
| EP1063995B1 (en) | Combination for the treatment of alcohol dependence containing an opioid antagonist and a nmda receptor complex modulator | |
| JP2000507544A (ja) | 痛みの治療方法 | |
| CN109475539B (zh) | 帕金森氏病的治疗 | |
| SK7542003A3 (en) | Medicinal compositions containing aspirin | |
| CA2167004C (en) | Agent for treating mental disorders associated with cerebrovascular disorders | |
| JPH01100118A (ja) | ホスホジエステラーゼ阻害剤及びトロンボキサンａ↓２拮抗剤を含む新規な医薬組成物、その使用及びその製造法 | |
| SK17682002A3 (sk) | Liečivá na prevenciu a liečbu neurodegeneratívnych ochorení | |
| EA015483B1 (ru) | ПРИМЕНЕНИЕ ИНГИБИТОРА p38 КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ ПСИХИАТРИЧЕСКИХ РАССТРОЙСТВ | |
| US20080275075A1 (en) | Medicine Comprising a Combination of an Acetylcholinesterase Inhibitor and a 5-Substituted-3-Oxadiazolyl-1,6-Naphthyridin-2(1H)-One Derivative | |
| AU2021349680B2 (en) | Use of sphingosine-1-phosphate receptor agonist | |
| JP2004508272A (ja) | アセチルコリンエンハンサー | |
| RU2761219C2 (ru) | Терапевтическое средство от расстройств, связанных с употреблением алкоголя | |
| JP2002249432A (ja) | 併用剤 | |
| MXPA04012706A (es) | Tratamiento de combinacion para depresion y ansiedad. | |
| JP2009510158A (ja) | 毒物依存症の治療におけるネボグラミンの使用 | |
| CA2423364A1 (en) | Preventives/remedies for emotional disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB9A | Suspension of patent application procedure |